Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 25:9:914356.
doi: 10.3389/fmed.2022.914356. eCollection 2022.

Endometriosis and irritable bowel syndrome: A systematic review and meta-analyses

Michelle Y Nabi  1 , Samal Nauhria  2 , Morgan Reel  1 , Simon Londono  1 , Anisha Vasireddi  1 , Mina Elmiry  1 , Prakash V A K Ramdass  1
Affiliations

Endometriosis and irritable bowel syndrome: A systematic review and meta-analyses

Michelle Y Nabi et al. Front Med (Lausanne). .

Abstract

Objective: To estimate the pooled odds ratio of endometriosis and irritable bowel syndrome, and to estimate the pooled prevalence of irritable bowel syndrome in patients with endometriosis.

Data sources: Using Cochrane Library, MEDLINE, Science Direct, ClinicalTrials.gov, Web of Science, and CINAHL, we conducted a systematic literature search through October 2021, using the key terms "endometriosis" and "irritable bowel syndrome." Articles had to be published in English or Spanish. No restriction on geographical location was applied.

Methods of study selection: The following eligibility criteria were applied: full-text original articles; human studies; studies that investigated the association between endometriosis and irritable bowel syndrome. Two investigators screened and reviewed the studies. A total of 1,776 studies were identified in 6 separate databases. After screening and applying the eligibility criteria, a total of 17 studies were included for analyses. The meta-analysis of association between endometriosis and irritable bowel syndrome included 11 studies, and the meta-analysis on the prevalence of irritable bowel syndrome in endometriosis included 6 studies.

Tabulation integration and results: Overall 96,119 subjects were included in the main meta-analysis (11 studies) for endometriosis and irritable bowel syndrome, with 18,887 endometriosis patients and 77,171 controls. The odds of irritable bowel syndrome were approximately 3 times higher among patients with endometriosis compared with healthy controls (odds ratio 2.97; 95% confidence interval, 2.17 - 4.06). Similar results were obtained after subgroup analyses by endometriosis diagnosis, irritable bowel syndrome diagnostic criteria, and Newcastle-Ottawa Scale scores. Six studies reported prevalence rates of irritable bowel syndrome in women with endometriosis, ranging from 10.6 to 52%. The pooled prevalence of irritable bowel syndrome in women with endometriosis was 23.4% (95% confidence interval, 9.7 - 37.2).

Conclusion: Patients with endometriosis have an approximately threefold increased risk of developing irritable bowel syndrome. Development and recent update of Rome criteria has evolved the diagnosis of IBS, potential bias should still be considered as there are no specific tests available for diagnosis.

Systematic review registration: [https://www.crd.york.ac.uk/prospero/displa y_record.php?ID=CRD42018080611], identifier [CRD42018080611].

Keywords: endometriosis; functional gastrointestinal disorders; irritable bowel syndrome; meta-analyses; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Flow diagram shows the included studies for the systematic review and meta-analysis on endometriosis and irritable bowel syndrome.
FIGURE 2
FIGURE 2
Forest plot by all criteria.
FIGURE 3
FIGURE 3
Forest plot by endometriosis diagnosis.
FIGURE 4
FIGURE 4
Forest plot by IBS criteria.
FIGURE 5
FIGURE 5
Forest plot by NOS score.
FIGURE 6
FIGURE 6
Forest plot by prevalence of IBS.
FIGURE 7
FIGURE 7
Funnel plot.
See this image and copyright information in PMC

References

    1. Moore JS, Gibson PR, Perry RE, Burgell RE. Endometriosis in patients with irritable bowel syndrome: specific symptomatic and demographic profile, and response to the low FODMAP diet. Aust N Z J Obstet Gynaecol. (2017) 57:201–5. 10.1111/ajo.12594 - DOI - PubMed
    1. Seaman HE, Ballard KD, Wright JT, de Vries CS. Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: findings from a national case-control study–Part 2. BJOG. (2008) 115:1392–6. 10.1111/j.1471-0528.2008.01879.x - DOI - PubMed
    1. Surrey ES, Soliman AM, Johnson SJ, Davis M, Castelli-Haley J, Snabes MC. Risk of developing comorbidities among women with endometriosis: a retrospective matched cohort study. J Womens Health (Larchmt). (2018) 27:1114–23. 10.1089/jwh.2017.6432 - DOI - PubMed
    1. Ghiasi M, Kulkarni MT, Missmer SA. Is endometriosis more common and more severe than it was 30 years ago? J Minim Invasive Gynecol. (2020) 27:452–61. 10.1016/j.jmig.2019.11.018 - DOI - PubMed
    1. Maddern J, Grundy L, Castro J, Brierley SM. Pain in endometriosis. Front Cell Neurosci. (2020) 14:590823. 10.3389/fncel.2020.590823 - DOI - PMC - PubMed

Publication types